Over the past decade, technically reliable circulating tumor cell (CTC) detection methods
allowed the collection of large datasets of CTC counts in cancer patients. These data can be …

Abstract Blood testing using Circulating Tumor Cells (CTCs) has emerged as one of the
hottest fields in cancer diagnosis. Research on CTCs present nowadays a challenge, as …

Abstract Circulating Tumor Cells (CTC) are shed from primary or secondary tumors. Prior
studies have demonstrated that enumeration of CTC is a robust independent prognostic …

The enumeration of circulating tumor cells has long been regarded as an attractive
diagnostic tool, as circulating tumor cells are thought to reflect aggressiveness of the tumor …

Circulating Tumour Cells (CTCs) can be released from the primary tumour into the
bloodstream and may colonize distant organs giving rise to metastasis. The presence of …

Circulating tumor cells (CTCs) play a major role in the metastatic spread of breast cancer.
CTC detection has proven to be an important parameter for predicting progression free and …

Circulating tumor cells (CTCs) are particularly rare in non-metastatic breast cancer, and the
clinical validity of CTC detection in that clinical setting was initially not well recognized. A …

Circulating tumor cells (CTCs) provide unique information for the management of breast
cancer patients, since their detection and monitoring is useful for prognosis, prediction of …

Metastatic breast cancer (MBC) is typically an incurable disease with high mortality rates;
thus, early identification of metastatic features and disease recurrence through precise …

Circulating tumours cells (CTCs) represent an important biologic link in the spread of breast
cancer from primary to metastatic disease. CTCs are strong predictors of prognosis in …